170 related articles for article (PubMed ID: 23876099)
1. Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms.
Seegmiller AC; Wasserman A; Kim AS; Kressin MK; Marx ER; Zutter MM; Mosse CA
Leuk Lymphoma; 2014 Mar; 55(3):601-5. PubMed ID: 23876099
[TBL] [Abstract][Full Text] [Related]
2. Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization: Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes.
He R; Wiktor AE; Durnick DK; Kurtin PJ; Van Dyke DL; Tefferi A; Patnaik MS; Ketterling RP; Hanson CA
Am J Clin Pathol; 2016 Jul; 146(1):86-94. PubMed ID: 27353768
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the utility of peripheral blood vs bone marrow in karyotype and fluorescence in situ hybridization for myelodysplastic syndrome diagnosis.
Asadi Fakhr Z; Mehrzad V; Izaditabar A; Salehi M
J Clin Lab Anal; 2018 Nov; 32(9):e22586. PubMed ID: 29893006
[TBL] [Abstract][Full Text] [Related]
4. The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failure.
Jiang H; Xue Y; Wang Q; Pan J; Wu Y; Zhang J; Bai S; Wang Q; He G; Sun A; Wu D; Chen S
Leuk Res; 2012 Apr; 36(4):448-52. PubMed ID: 22047706
[TBL] [Abstract][Full Text] [Related]
5. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
6. [Detection of chromosome abnormalities in myelodysplastic syndromes with interval fluorescence in situ hybridization].
Ru X; Li Q; Fang XS; Li Y; Wang X; Zhang LY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):116-20. PubMed ID: 23484703
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Utility of Bone Marrow Morphology and Ancillary Studies in Pediatric Patients Under Surveillance for Myelodysplastic Syndrome.
Chisholm KM; Xu M; Davis B; Ogi A; Pacheco MC; Geddis AE; Tsuchiya KD; Rutledge JC
Am J Clin Pathol; 2018 Apr; 149(6):499-513. PubMed ID: 29659673
[TBL] [Abstract][Full Text] [Related]
8. Clonal origin and evolution of myelodysplastic syndrome analyzed by dysplastic morphology and fluorescence in situ hybridization.
Fu CM; Chen ZX; Liu DD; Zhang J; Pan JL; Liang JY
Int J Hematol; 2015 Jan; 101(1):58-66. PubMed ID: 25430081
[TBL] [Abstract][Full Text] [Related]
9. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
10. Is fluorescence in-situ hybridization sufficient in patients with myelodysplastic syndromes and insufficient cytogenetic testing?
Merkel D; Soffer S; Novikov I; Avigdor A; Amariglio N; Nagler A; Trakhtenbrot L
Leuk Lymphoma; 2019 Mar; 60(3):764-771. PubMed ID: 30187812
[TBL] [Abstract][Full Text] [Related]
11. Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype.
Rigolin GM; Bigoni R; Milani R; Cavazzini F; Roberti MG; Bardi A; Agostini P; Della Porta M; Tieghi A; Piva N; Cuneo A; Castoldi G
Leukemia; 2001 Dec; 15(12):1841-7. PubMed ID: 11753603
[TBL] [Abstract][Full Text] [Related]
12. Prognostic classification of MDS is improved by the inclusion of FISH panel testing with conventional cytogenetics.
Kokate P; Dalvi R; Koppaka N; Mandava S
Cancer Genet; 2017 Oct; 216-217():120-127. PubMed ID: 29025586
[TBL] [Abstract][Full Text] [Related]
13. FISH analysis in addition to G-band karyotyping: utility in evaluation of myelodysplastic syndromes?
Yang W; Stotler B; Sevilla DW; Emmons FN; Murty VV; Alobeid B; Bhagat G
Leuk Res; 2010 Apr; 34(4):420-5. PubMed ID: 19800120
[TBL] [Abstract][Full Text] [Related]
14. Analysis of hematologic diseases using conventional karyotyping, fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH).
Wilkens L; Tchinda J; Burkhardt D; Nolte M; Werner M; Georgii A
Hum Pathol; 1998 Aug; 29(8):833-9. PubMed ID: 9712425
[TBL] [Abstract][Full Text] [Related]
15. Identify latent chromosomal aberrations relevant to myelodysplastic syndromes.
Song Q; Chu Y; Yao Y; Peng M; Yang W; Li X; Huang S
Sci Rep; 2017 Sep; 7(1):10354. PubMed ID: 28871208
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic and FISH analyses in five patients with hypoplastic bone marrow.
Bernasconi P; Astori C; Cavigliano PM; Boni M; Malcovati L; Calatroni S; Caresana M; Bernasoconi C
Leukemia; 2000 Jul; 14(7):1322-3. PubMed ID: 10914562
[No Abstract] [Full Text] [Related]
17. [Karyotype studies of patients with a myelodysplastic syndrome].
Salamanchuk ZIa; Masliak ZV; Lozyns'ka MR; Vyhovs'ka IaI; Lohins'kyĭ VIe; Male P
Tsitol Genet; 1998; 32(1):43-8. PubMed ID: 9695251
[TBL] [Abstract][Full Text] [Related]
18. [A comparative study of fluorescence in situ hybridization versus conventional cytogenetics in the detection of clonal aberrations in myelodysplastic syndrome].
Lai YY; Li N; Feng L; Shi Y; Dang H; He Q; Wang Z; Wang XY; Li Y; Liu Q; Huang XJ
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3175-9. PubMed ID: 24405535
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and prognosis in myelodysplastic syndromes. The impact of cytogenetics].
Mecucci C
Recenti Prog Med; 2014 Mar; 105(3):110-4. PubMed ID: 24675452
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization panel for monitoring of minimal residual disease in patients with double minute chromosomes.
Jeon Y; Kim SY; Kim M; Park HK; Lee SH; See CJ; Kwon J; Lee DS
Blood Cells Mol Dis; 2014 Apr; 52(4):208-13. PubMed ID: 24211232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
